Clinical Trials in Los Angeles

Showing 7201-7220 of 12,794 trials

A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH

NCT02264639

This study will be the initial exploration of pegcetacoplan in patients with PNH. The assessments of the safety, tolerability, PK, and PD following administration of single and multiples doses of pegcetacoplan will guide decisions to further develop the drug.

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Apellis Pharmaceuticals, Inc.9 participantsStarted Feb 2015

Los Angeles, California, United States • Miami Lakes, Florida, United States • Louisville, Kentucky, United States +4 more locations

COMPLETEDPhase 3< 1 mile

A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

NCT04608500

The primary objectives of this study are to determine the efficacy and safety of FMX103 1.5% minocycline foam applied topically once daily for 12 weeks in the treatment of rosacea.

Facial Papulopustular Rosacea

Vyne Therapeutics Inc.771 participantsStarted Jun 2017

Glendale, Arizona, United States • Hot Springs, Arkansas, United States • Rogers, Arkansas, United States +43 more locations

A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH

A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Find Trials by Condition in Los Angeles

Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza

A Long-Term Study of Rovalpituzumab Tesirine

Dose Range Finding Study of Bimagrumab in Sarcopenia

Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes

Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy

Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Clinical Study of Approved Contact Lenses

Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

A Study of CLR325 in Chronic Stable Heart Failure Patients.